Nuxera AI

Nuxera AI is a Riyadh-based healthtech startup whose SERA tool turns doctor and patient conversations in Arabic dialects into coded clinical notes. It raised USD 2.5 million pre-seed in October 2025.

Industry: Healthcare voice AI and clinical documentation | Location: Riyadh, Saudi Arabia | Founded: 2024 | Total Funding: USD 2.5M

About Nuxera AI

Nuxera AI is a Riyadh-based company that builds voice artificial intelligence for healthcare documentation in Saudi Arabia. Its website describes the company as Saudi-built and Saudi-hosted, and says it aims to reduce the documentation burden on healthcare providers.

Nuxera was founded in 2024 by Amin El Hemaily, Asad Khan and Nada Hassan. El Hemaily is co-founder and chief executive officer, Khan is co-founder and chief technology officer, and Hassan is co-founder and chief business officer, a title that the funding coverage gives as chief commercial officer. The company's site describes Hassan as a pharmacist turned healthtech leader.

The flagship product is SERA, an ambient scribing tool that captures doctor and patient conversations in 28 Arabic dialects and produces structured clinical notes coded to SNOMED, ACHI, SBS and ICD-10. Nuxera says SERA cuts documentation time by more than 70 percent and fits into existing hospital systems. The website lists versions for clinicians and for nursing. A second tool, Talk to Your Data, lets hospital leaders ask questions in plain Arabic about clinical, operational and financial matters.

Nuxera targets public health clusters and private hospitals. Its website lists the Ministry of Health, Aster Sanad, King Abdullah Medical City, National Guard Health Affairs, Hayat National Hospitals and the Taif, Hail and Eastern Health Clusters as clients, without describing the scope of each engagement. The site also states that the company is compliant with HIPAA and the Council of Health Insurance requirements and holds ISO 27001 certification; these are company statements that were not checked against an issuer register.

In October 2025 Nuxera announced a USD 2.5 million pre-seed investment from Sanabil Venture Studio by Redesign Health, and Wamda reported on 8 October 2025 that it was the first company to emerge from that studio. The company said the money would expand its engineering and go-to-market teams in Saudi Arabia, support further hospital deployments and improve its models through clinical collaborations.

Leadership